-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused
-
-infiltrating lymphocytes and gene-engineered T cells. Postdoctoral Associates are expected to establish an innovative, collaborative research program addressing important and fundamental questions. Active areas
-
at the intersection of computational modeling, data science, and clinical medicine. The successful candidate will work closely with clinicians, intensivists, and computational scientists to develop
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused
-
and vision sufficient for standard laboratory operations and computer data entry and analysis. Lifting up to 25lbs. WORK ENVIRONMENT: Lab environment. Universal precautions are mandatory. Special
-
Institute of New Jersey Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will
-
neuroscience research with clinical applications to addiction and other mental health concerns. Our work draws on methods from psychology, experimental economics, human neuroscience, and computational psychiatry
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused
-
Overview RUTGERS CANCER INSTITUTE VISION, MISSION, AND CORE VALUES: VISION: Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused